Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Increase the proportion of people on Medicare with chronic kidney disease who get recommended tests — CKD‑04

Status: Improving

  
Improving
Learn more about our data release schedule

Most Recent Data:
38.9 percent (2021)

Target:
49.5 percent 1

Desired Direction:
Increase desired

Baseline:
36.6 percent of Medicare beneficiaries aged 65 years and over with chronic kidney disease received medical evaluation with serum creatinine, lipids, and urine albumin tests in 2016 2

See detailed data for this objective

Increase the proportion of Medicare beneficiaries with chronic kidney disease who receive medical evaluation with serum creatinine, lipids, and urine albumin tests

Target-Setting Method
Projection

Data Source:  United States Renal Data System (USRDS), NIH/NIDDK

Learn more about data measurement for this objective

Summary

Testing for serum creatinine, lipids, and urine albumin is important in people with chronic kidney disease (CKD). Health care providers can use these tests to see how well kidneys are working, find out if CKD has gotten worse, and decide the best course of treatment. Research has shown that using these 3 tests can help prevent or delay end-stage kidney disease.

Topics:  Chronic Kidney Disease, Diabetes, Health Care

Workgroup: Chronic Kidney Disease Workgroup

Other objectives you may be interested in

Browse all Healthy People 2030 objectives

1. Target has been revised. See Data Methodology and Measurement for more information.

2. Baseline has been revised. See Data Methodology and Measurement for more information.